menu search

Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA Against Gimoti

Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA Against Gimoti
Stipulation of Dismissal of Claims, Defenses and Counterclaims for Patent Infringement Case Filed SOLANA BEACH, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today announced that a joint stipulation of dismissal […] The post Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA Against Gimoti appeared first... Read More
Posted: Jan 30 2023, 12:00
Author Name: forextv
Views: 0921100

Search within

Pages Search Results: